126 related articles for article (PubMed ID: 2836111)
1. Structural relationships of angiotensin converting-enzyme inhibitors to pharmacologic activity.
Ondetti MA
Circulation; 1988 Jun; 77(6 Pt 2):I74-8. PubMed ID: 2836111
[TBL] [Abstract][Full Text] [Related]
2. [Angiotensin-converting enzyme inhibitors as neutralizers of hydroxyl radical].
Mira ML; Silva MM; Queirós MJ; Manso C
Rev Port Cardiol; 1992 May; 11(5):425-30. PubMed ID: 1325814
[TBL] [Abstract][Full Text] [Related]
3. Differential influences of angiotensin converting-enzyme inhibitors on the coronary circulation.
van Gilst WH; Scholtens E; de Graeff PA; de Langen CD; Wesseling H
Circulation; 1988 Jun; 77(6 Pt 2):I24-9. PubMed ID: 3286044
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
Udupa EG; Rao NM
Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
[TBL] [Abstract][Full Text] [Related]
6. Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice.
Sarro GD; Paola ED; Gratteri S; Gareri P; Rispoli V; Siniscalchi A; Tripepi G; Gallelli L; Citraro R; Russo E
Pharmacol Res; 2012 Mar; 65(3):285-96. PubMed ID: 22107891
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
[TBL] [Abstract][Full Text] [Related]
8. Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin systems: correlation of chemical structure and biologic activity.
Zusman RM
Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):13-23. PubMed ID: 3037886
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and enzyme inhibitory activities of new trifluoromethyl-containing inhibitors for angiotensin converting enzyme.
Ojima I; Jameison FA; Pete B; Radunz H; Schittenhelm C; Lindner HJ; Emith AE
Drug Des Discov; 1994 Feb; 11(2):91-113. PubMed ID: 8075303
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin converting enzyme inhibitors on tolerance of nitroglycerin.
Fang Z; Li Y; Liu D; Li Y; Hao F; Liu Z
Chin Med J (Engl); 1995 Dec; 108(12):919-22. PubMed ID: 8728945
[TBL] [Abstract][Full Text] [Related]
11. Characterization of angiotensin converting enzyme by [3H]captopril binding.
Strittmatter SM; Snyder SH
Mol Pharmacol; 1986 Feb; 29(2):142-8. PubMed ID: 3005826
[TBL] [Abstract][Full Text] [Related]
12. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
Raasch W; Bartels T; Schwartz C; Häuser W; Rütten H; Dominiak P
J Hypertens; 2002 Dec; 20(12):2495-504. PubMed ID: 12473875
[TBL] [Abstract][Full Text] [Related]
13. [Synthesis of angiotensin converting enzyme inhibitors containing residues of substituted quinolines and a study of their biological activity].
Filatova MP; Krit NA; Uskova NN; Maksimova EM; Gracheva IN; Reĭssmann Z
Bioorg Khim; 1991 May; 17(5):690-6. PubMed ID: 1662954
[TBL] [Abstract][Full Text] [Related]
14. Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors.
Van Antwerpen P; Legssyer I; Zouaoui Boudjeltia K; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
Eur J Pharmacol; 2006 May; 537(1-3):31-6. PubMed ID: 16631159
[TBL] [Abstract][Full Text] [Related]
15. The influence of angiotensin-converting enzyme inhibitors on the aorta elastin metabolism in diet-induced hypercholesterolaemia in rabbits.
Wojakowski W; Gminski J; Siemianowicz K; Goss M; Machalski M
J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):37-42. PubMed ID: 11881065
[TBL] [Abstract][Full Text] [Related]
16. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
[TBL] [Abstract][Full Text] [Related]
17. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin analogs as inhibitors of angiotensin-converting enzyme.
Chaturvedi D; Huelar E; Gunthorpe M; Gofman M; Krapf DS; Apostol E; Lewis WS
Pept Res; 1993; 6(6):308-12. PubMed ID: 8292848
[TBL] [Abstract][Full Text] [Related]
19. Drugs inhibiting the renin - angiotensin system.
Antonaccio MJ; Cushman DW
Fed Proc; 1981 Jun; 40(8):2275-84. PubMed ID: 6263716
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-9/tissue inhibitors of metalloproteinase-1 expression and atrial structural remodeling in a dog model of atrial fibrillation: inhibition with angiotensin-converting enzyme.
Zhang W; Zhong M; Yang GR; Li JP; Guo C; Wang Z; Zhang Y
Cardiovasc Pathol; 2008; 17(6):399-409. PubMed ID: 18706834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
